S'abonner

Monocyte chemotactic protein–induced protein 1 controls allergic airway inflammation by suppressing IL-5–producing TH2 cells through the Notch/Gata3 pathway - 04/08/18

Doi : 10.1016/j.jaci.2017.09.031 
Hui Peng, PhD a, Huan Ning, MS a, Qinghong Wang, PhD a, Wenbao Lu, PhD a, Yingzi Chang, PhD b, Tony T. Wang, PhD c, Jinping Lai, MD, PhD d, Pappachan E. Kolattukudy, PhD e, Rong Hou, MD, PhD a, Daniel F. Hoft, MD, PhD a, Mark S. Dykewicz, MD a, Jianguo Liu, MD, PhD a,
a Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo 
d Department of Pathology, Saint Louis University School of Medicine, Saint Louis University School of Medicine, St Louis, Mo 
b Pharmacology Department, A.T. Still University, Kirksville, Mo 
c SRI International, Harrisonburg, Va 
e Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Fla 

Corresponding author: Jianguo Liu, MD, PhD, Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, 1100 S Grand Blvd, DRC Rm 811, St Louis, MO 63104.Division of Infectious Diseases, Allergy and ImmunologyDepartment of Internal MedicineSaint Louis University School of Medicine1100 S Grand Blvd, DRC Rm 811St LouisMO63104

Abstract

Background

Asthmatic and allergic inflammation is mediated by TH2 cytokines (IL-4, IL-5, and IL-13). Although we have learned much about how TH2 cells are differentiated, the TH2 checkpoint mechanisms remain elusive.

Objectives

In this study we investigate how monocyte chemotactic protein–induced protein 1 (MCPIP1; encoded by the Zc3h12a gene) regulates IL-5–producing TH2 cell differentiation and TH2-mediated inflammation.

Methods

The functions of Zc3h12a−/− CD4 T cells were evaluated by checking the expression of TH2 cytokines and transcription factors in vivo and in vitro. Allergic airway inflammation of Zc3h12a−/− mice was examined with murine asthma models. In addition, antigen-specific CD4 T cells deficient in MCPIP1 were transferred to wild-type recipient mice, challenged with ovalbumin (OVA) or house dust mite (HDM), and accessed for TH2 inflammation.

Results

Zc3h12a−/− mice have spontaneous severe lung inflammation, with an increase in mainly IL-5– and IL-13–producing but not IL-4–producing TH2 cells in the lung. Mechanistically, differentiation of IL-5–producing Zc3h12a−/− TH2 cells is mediated through Notch signaling and Gata3 independent of IL-4. Gata3 mRNA is stabilized in Zc3h12a−/− TH2 cells. MCPIP1 promotes Gata3 mRNA decay through the RNase domain. Furthermore, deletion of MCPIP1 in OVA- or HDM-specific T cells leads to significantly increased TH2-mediated airway inflammation in OVA or HDM murine models of asthma.

Conclusions

Our study reveals that MCPIP1 regulates the development and function of IL-5–producing TH2 cells through the Notch/Gata3 pathway. MCPIP1 represents a new and promising target for the treatment of asthma and other TH2-mediated diseases.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : RNA-Binding protein, MCPIP1, mRNA decay, TH2 cells, IL-4, IL-5, IL-13, Gata3, Notch, asthma

Abbreviations used : BALF, CARMA1, DLL, GSI, HDM, H&E, ILC2, MCPIP-1, OVA, PAS, PMA, shRNA, STAT, TCR, UTR, WT


Plan


 Supported by the National Cancer Institute of the National Institutes of Health under award no. R01CA163808 (to J.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 Disclosure of potential conflict of interest: T. T. Wang's institution received a grant from the National Institute of Diabetes and Digestive and Kidney Disease for this work. M. S. Dykewicz personally received consultant fees from Alcon and Merck for other works. The rest of the authors declare that they have no relevant conflicts of interest.


© 2017  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 2

P. 582 - août 2018 Retour au numéro
Article précédent Article précédent
  • Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells
  • Mohamed H. Shamji, Jeff N. Temblay, Wei Cheng, Susan M. Byrne, Ellen Macfarlane, Amy R. Switzer, Natalia D.C. Francisco, Fedina Olexandra, Fabian Jacubczik, Stephen R. Durham, Philip G. Ashton-Rickardt
| Article suivant Article suivant
  • RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease
  • Huawei Mao, Wanling Yang, Sylvain Latour, Jing Yang, Sarah Winter, Jian Zheng, Ke Ni, Minmin Lv, Chenjing Liu, Hongmei Huang, Koon-Wing Chan, Pamela Pui-Wah Lee, Wenwei Tu, Alain Fischer, Yu-Lung Lau

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.